ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 56 filers reported holding ONCOCYTE CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,448,000 | -46.8% | 1,027,493 | -20.7% | 0.00% | -100.0% |
| Q4 2021 | $2,722,000 | -51.3% | 1,296,516 | -8.0% | 0.00% | -50.0% |
| Q3 2021 | $5,592,000 | -33.4% | 1,408,681 | -3.7% | 0.00% | -33.3% |
| Q2 2021 | $8,392,000 | +65.2% | 1,462,164 | +49.4% | 0.00% | +50.0% |
| Q1 2021 | $5,081,000 | +776.0% | 978,844 | +302.9% | 0.00% | – |
| Q4 2020 | $580,000 | +88.3% | 242,935 | +9.8% | 0.00% | – |
| Q3 2020 | $308,000 | -42.5% | 221,341 | -21.1% | 0.00% | – |
| Q2 2020 | $536,000 | +152.8% | 280,515 | +224.1% | 0.00% | – |
| Q1 2020 | $212,000 | +60.6% | 86,543 | +47.0% | 0.00% | – |
| Q4 2019 | $132,000 | -6.4% | 58,878 | -12.0% | 0.00% | – |
| Q3 2019 | $141,000 | -42.7% | 66,896 | -32.2% | 0.00% | – |
| Q2 2019 | $246,000 | – | 98,697 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |